Alto Ingredients is trading at $4.13, down -5.92%, under pressure after establishing a $50 million at-the-market equity program, raising dilution and funding concerns.

  • The decline follows a strong Q2 report, suggesting investors are prioritizing the financing announcement over earnings.
  • Broader markets are mixed, making company-specific dilution concerns the primary catalyst.